Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2026
Beyond the Burden: Elevating Immunotherapy in Colorectal CancerChristine M Parseghian, Madhulika EluriClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2022
Truncal Dynamics May Trump: Serial ctDNA to Predict Early Therapeutic ResponseMadhulika Eluri, Scott Kopetz, Christine M ParseghianCancer Cell|January 18, 2020
This Is Our Cells Under Pressure: Decreased DNA Damage Repair in Response to Targeted Therapies Facilitates the Emergence of Drug-Resistant ClonesCarl M Gay, Christine M Parseghian, Lauren Averett ByersClinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2019
Mechanisms of Innate and Acquired Resistance to Anti-EGFR Therapy: A Review of Current Knowledge with a Focus on Rechallenge TherapiesChristine M Parseghian, Stefania Napolitano, Jonathan M Loree, et al.JAMA Oncology|November 2, 2018
Assessment of Reported Trial Characteristics, Rate of Publication, and Inclusion of Mandatory Biopsies of Research Biopsies in Clinical Trials in OncologyChristine M Parseghian, Alda L Tam, James Yao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2017
Underreporting of Research Biopsies from Clinical Trials in OncologyChristine M Parseghian, Kanwal Raghav, Robert A Wolff, et al.NPJ Precision Oncology|February 5, 2025
BRAF mutant appendiceal adenocarcinoma differs from colorectal cancer but responds to BRAF-targeted therapyVinay K Pattalachinti, Emaan Haque, Mahmoud Yousef, et al.JCO Precision Oncology|September 11, 2020
Atypical, Non-V600 BRAF Mutations as a Potential Mechanism of Resistance to EGFR Inhibition in Metastatic Colorectal CancerBenny Johnson, Jonathan M Loree, Alexandre A Jacome, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2018
Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated With ImmunotherapyChristine M Parseghian, Madhavi Patnana, Priya Bhosale, et al.BMC Cancer|July 22, 2025
Detection of oncogenic fusions in colorectal cancer using a partner-agnostic next-generation sequencing approachAndrew J Pellatt, Reagan M Barnett, Sante Gnerre, et al.Pageof 3